CIPLOX
250MG TBL FLM 50(5X10)
SÚKL code | 0015654 |
---|---|
Name of the product | CIPLOX |
_MA_MEDICATION_DETAIL_INFO_MED_NAME i | CIPLOX |
Supplement | 250MG TBL FLM 50(5X10) |
Strenght | 250MG |
Pharmaceutical form | Film-coated tablet |
Package | 50(5X10) |
Route | Oral use |
Language of the pack | Czech |
Wrap type | Blister |
Legal status | na lékařský předpis |
Active substance | CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE (CIPROFLOXACINI HYDROCHLORIDUM MONOHYDRICUM) |
ATC group | J01MA02 |
ATC group name | CIPROFLOXACIN |
Marketing authorisation information
Registration Number | 42/1236/97-C |
---|---|
Type of MA | National |
MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
Placed on the market till | 31. 07. 2019 |
MA Holder | Cipla (UK) Limited, Addlestone |
MA Holder country | VELKÁ BRITÁNIE |
Actual MA holder | Cipla Europe NV, Antverpy |
Actual MA holder country | BELGIE |